REQUEST A DEMO
Total
USD $0.00
Search more companies

Nkgen Biotech Korea Co., Ltd. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Nkgen Biotech Korea Co., Ltd. Profile Updated: September 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Nkgen Biotech Korea Co., Ltd. is a company in South Korea, with a head office in Seongnam. The company operates in the Research and Development in Nanotechnology industry. It was established on January 14, 2002. The total number of employees is currently 70 (2025). The company’s latest financial report indicates a net sales revenue drop of 10.65% in 2025. Over the same period, its total assets decreased by 38.44%. In 2025, Nkgen Biotech Korea Co., Ltd.’s net profit margin increased by 309.7%.

Headquarters
1F, 6F, 172, Dolma-Ro, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 13605

Contact Details: Purchase the Nkgen Biotech Korea Co., Ltd. report to view the information.

Website: http://www.nkvue.com

Basic Information
Total Employees:
Purchase the Nkgen Biotech Korea Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Nkgen Biotech Korea Co., Ltd. report to view the information.
Registered Capital:
Purchase the Nkgen Biotech Korea Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Nkgen Biotech Korea Co., Ltd. report to view the information.
Incorporation Date:
January 14, 2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
14.3%
Purchase this report to view the information.
12.4%
Purchase this report to view the information.
5.1%
Subsidiaries
(주)엔케이맥스에이치앤디
Atgen America Inc
Atgen Canada Inc
Company Performance
Financial values in the chart are available after Nkgen Biotech Korea Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-10.65%▼
Total Operating Revenue
-53.56%▼
Operating Profit
82.82%▲
EBITDA
-73.3%▼
Net Profit/Loss for the Period
79.3%▲
Total Assets
-38.44%▼
Total Equity
N/A
Operating Profit Margin
312.88%▲
Net Profit Margin
309.7%▲
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
1.71%▲
Cash Ratio
0.24%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?